Relation of cardiac sympathetic innervation to proinflammatory cytokine levels in patients with heart failure secondary to idiopathic dilated cardiomyopathy

American Journal of Cardiology

Volumn 91, Issue 10, 2003, Pages 1190-1194

  Parthenakis, Fragiskos I ^a   Patrianakos, Alexandros ^a   Prassopoulos, Vasilis ^a   Papadimitriou, Evangelos ^a   Nikitovic, Dragana ^a   Karkavitsas, Nikos S ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; IODINE 123; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADRENERGIC SYSTEM; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EXERCISE; FEMALE; HEART FAILURE; HEART INNERVATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL; HEART STRESS; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; MEDIASTINUM; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYMPATHETIC INNERVATION;

EID: 0038402503     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00265-0     Document Type: Article

References (28)

1. Bristow M.R. β-adrenergic receptor blockade in chronic heart failure. Circulation. 101:2000;558-569.
2. Ìunger M.A., Johnson B., Amber I.J., Callahan K.S., Gilbert E. Circulating concentrations of pro-inflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 77:1996;723-727.
3. Guirao X., Kumar A., Katz J., Smith M., Lin E., Keogh C., Calvano S.E., Lowry S.F. Catecholamines increase monocyte TNF receptors and inhibit TNF through beta 2-adrenoreceptor activation. Am J Physiol. 273:1997;E1203-1208.
4. Hasko G., Nemeth Z.H., Szabo C., Zsilla G., Salzman A.L., Vizi E.S. Isoproterenol inhibits Il-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages. Brain Res Bull. 45:1998;183-187.
5. Schofer J., Spielmann R., Schuchert A., Weber K., Schlutter M. Iodine-123 metaiodobenzylguanidine scintigraphy a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy . J Am Coll Cardiol. 12:1988;1252-1258.
6. Sisson J.C., Shapiro B., Meyers L., Mallette S., Mangner T.J., Wieland D.M., Glowniak J.V., Sherman P., Beierwaltes W.H. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med. 28:1987;1625-1636.
7. Imamura Y., Ando H., Mitsuoka W., Egashira S., Masaki H., Ashihara T., Fukuyama T. Iodine-123metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol. 26:1995;1594-1599.
8. Cohen-Solal A., Esanu Y., Logeart D., Pessione F. Cardiac metaiodobenzyl-guanidine uptake in patients with moderate chronic heart failure. Relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol. 33:1999;759-766.
9. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 2:1989;358-367.
10. Reichek N., Wilson J., Sutton M., Plappert T.A., Goldberg S., Hirshfeld J.W. Non-invasive determination of left ventricular end-systolic wall stress validation of the method and clinical implications . Circulation. 65:1982;99-108.
11. Merlet P., Valette H., Dubois-Rande J.L., Moyse D., Duboc D., Dove P., Bourguignon M.H., Benvenuti C., Duval A.M., Agostini D. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 33:1992;471-477.
12. Feldman A.M., Combes A., Wagner D., Kadakomi T., Kubota T., Li Y.Y., McTiernan C. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol. 35:2000;537-544.
13. Taffet S.M., Singhel K.J., Overholtzer J.F., Shurtleff S.A. Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP. Cell Immunol. 120:1989;291-300.
14. Wagner D.R., Combes A., McTiernan C., Sanders V.J., Lemster B., Feldman A.M. Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha. Circulation Res. 82:1998;47-56.
15. Rundqvist B., Eisenhofer G., Elam M., Friberg P. Attenuated cardiac sympathetic responsiveness during dynamic exercise in patients with heart failure. Circulation. 95:1997;940-945.
16. Meredith I.T., Eisenhofer G., Lambert G.W., Dewar E.M., Jennings G.L., Esler M. Cardiac sympathetic nervous activity in congestive heart failure evidence for increased neuronal norepinephrine release and preserved neuronal uptake . Circulation. 88:1993;136-145.
17. Bohm M., Larosee K., Schwinger R.H.G., Erdman E. Evidence for a reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol. 25:1995;146-153.
18. Eisenhofer G., Friberg P., Rundqvist B., Quyyumi A.A., Lambert G., Kaye D.M., Kopin I.J., Goldstein D.S., Esler M.D. Cardiac sympathetic nerve function in congestive heart failure. Circulation. 93:1996;1667-1676.
19. Bristow M.R., Ginsburg R., Minobe W., Cubiciotti R.S., Sageman W.S., Lurie K., Billingham M.E., Harrison D.C., Stinson E.B. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med. 307:1982;205-211.
20. Neuman J., Schmitz W., von Meyericnk L., Scholz H., Doring V., Kalmar P. Increase in myocardial Gi-proteins in heart failure. Lancet. 2:1988;936-937.
21. Pierpont G.L., Francis G.S., DeMaster E.G., Olivari M.T., Ring W.S., Goldenberg I.F., Reynolds S., Cohn J.N. Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure. Am J Cardiol. 60:1987;316-321.
22. Glowniak J., Turner F., Gray L.L., Palac R.T., Lagunas-Solar M.C., Woodward W.R. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med. 30:1989;1182-1191.
23. Honda T., Ninomiya I., Azumi T. Cardiac sympathetic nerve activity and catecholamine kinetics in cat hearts. Am J Physiol. 252:1987;H879-H885.
24. Glowniak J., Kilty J.E., Amara S., Hoffman B.J., Turner F.E. Evaluation of metaiodobenzyl-guanidine uptake by the norepinephrine, dopamine and serotonin transporters. J Nucl Med. 34:1993;1140-1146.
25. Dae M., De Marco T., Botvinick E., O'Connell J.W., Hattner R.S., Hoberty J.P., Yuen-Green M.S. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts - implications for clinical studies. J Nucl Med. 33:1992;1444-1450.
26. Parthenakis F.I., Prassopoulos V.K., Koukouraki S.I., Zacharis E.A., Diakakis G.F., Karkavitsas N.K., Vardas P.E. Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy relationship to regional wall motion and myocardial perfusion abnormalities . J Nucl Cardiol. 9:2002;15-22.
27. Prabhu S.D., Chandrasekar B., Murray D.R., Freeman G.L. β-adrenergic blockade in developing heart failure. Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation. 101:2000;2103-2109.
28. Newman W.H., Castresana M.R., Webb J.G., Wang Z., Warejcka D.J. Stimulation of beta-adrenergic receptors inhibits the release of tumor necrosis factor-alpha from the isolated rat heart. Crit Care Med. 28:2000;3593-3598.